Viewing Study NCT00215280



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00215280
Status: COMPLETED
Last Update Posted: 2007-04-20
First Post: 2005-09-21

Brief Title: Epidemiology and Control of Mansonella Perstans Infection in Uganda
Sponsor: DBL -Institute for Health Research and Development
Organization: DBL -Institute for Health Research and Development

Study Overview

Official Title: Studies on the Epidemiology and Control of Mansonella Perstans Infection in Uganda
Status: COMPLETED
Status Verified Date: 2007-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Mansonella perstans M perstans infection is widespread in Uganda Knowledge about the epidemiology of this infection and of the morbidity it induces is poor and no effective treatment is available The study aims at providing data on diagnostic epidemiological morbidity and treatment aspects of M perstans infections in Uganda
Detailed Description: Overall objective to investigate diagnostic epidemiological and treatment aspects of M perstans in Uganda with relevance to control

Specific objectives

1 To establish the pattern of diurnal periodicity of M perstans microfilaraemia in humans
2 To establish the patterns of M perstans microfilaraemia and possible clinical manifestations related to this infection in two communities with medium to high endemicity
3 To determine the efficacy of ivermectin alone and the combination of ivermectin and albendazole on M perstans microfilaraemia

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None